Health | February 10, 2017 |
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro.
Quote of the Week
"[W]hat drove a lot of the initial hype and growth in digital health was people that came in without a lot of background in health care, they were brand new to healthcare. They were very technologically saavy and came in with this mentality of, "software is eating the world," the, "technology is the panacea" kind of mentality, and until you start getting deep in the weeds you won't realize exactly how complex healthcare is. So that is one of the issues, this mentality that technology can solve all problems, Although in healthcare some problems are technologically oriented, but a lot of them are people oriented."
- Vanessa Mason, co-founder P2Health
| Health Startup Digest is curated by: |  | R. Scott Munro - MBA Candidate at the University of Chicago Booth School of Business Contact R. Scott Munro at scott.munro@startupdigestmail.com | Learn how to become a Diversity Leader and actions you can take to improve diversity and inclusion in your company!  We surveyed nearly 700 founders of tech startups from around the world to gain insight into the challenges they face when working to build a diverse and inclusive company. Diversity Leaders take key steps in specific areas to create an inclusive environment: Mentoring and advising, hiring practices, professional development, pay and performance, and flexible benefits. Learn how you can become a Diversity Leader. | | Scott Munro - Medium I chatted with Vanessa Mason of P2 Health about her thoughts on public health, technology, and digital health more broadly. It was a great conversation that really highlighted areas I've been frustrated with in digital health today (i.e. some folks missing the broader health implications of the work, or ignoring at risk populations). Check out the entire interview! | | Damiano de Felice - HBR Damaino has a pretty low-bar for pharma to clear in this HBR piece: focus on unmet medical needs and avoid unethical business practices. In general, the author feels that, "[t]he message is clear: Pharma companies should treat underserved demographics as a growth opportunity, not as a lost cause." Read up more on the topic above. | | Eleven Two Capital - Medium I love when VCs write down their general investment theses because it sheds light on how they think about the world, especially on the early stage side. A buddy of mine at Eleven Two sent this over to show their thoughts on "Data-Driven Health" as they call it. It's got unique insights into how the explosion of data in health care will be creating opportunities for new and innovative companies. Check out more of their thoughts in the link above. | | The Commonwealth Fund - The Commonwealth Fund Commonwealth is doing a series on low-cost strategies for health interventions via their podcast. This week's was on a community health strategy deployed in Brazil that costs only around 30$ per person per year, and has had a lot of success. My interview with Vanessa this week really drove home the need for more low-cost, high impact solutions in the United States, and this series from Commonwealth is doing a great job of highlighting some strategies that have worked abroad. | | Barry L. Rosenberg, Joshua A. Kellar, Anna Labno, David H. M. Matheson, Michael Ringel, Paige VonAchen, Richard I. Lesser, Yue Li, Justin B. Dimick, Atul A. Gawande, Stefan H. Larsson, Hamilton Moses III - PLOS One This is a pretty meaty research piece put out by Atul Gawande and researchers from BCG. I'd recommend reading the whole thing, but the conclusion is quite interesting: "The amount of variability in health outcomes in the U.S. is large even after accounting for differences in population, co-morbidities, and health system factors. These findings suggest that: 1) additional examination of regional and local variation in risk-adjusted outcomes should be a priority; 2) assumptions of uniform hospital quality that underpin rationale for policy choices (such as narrow insurance networks or antitrust enforcement) should be challenged; and 3) there exists substantial opportunity for outcomes improvement in the US healthcare system." | | Julia Bradshaw - Telegraph Despite CRISPR Cas-9 winning "technology of the year" according to TechCrunch, the gene editing technology has been around for quite some time. What is new is how people are thinking about the commercial applications of the technology that has mostly been used in labs. An obvious commercial application is in pharma R&D to help test how different cell types will react to drugs. | | Sumedha Niranjan & Akhsar Kharebov - SV Health 2.0 The Silicon Valley Health 2.0 group invites you to come to their February chapter meeting, which will take place on Tuesday, February 21st. Silicon Valley Health is the largest health tech innovation meetup in the world. Their events offer a place for health innovators, professionals and stakeholders to network and share ideas. The monthly meetup is always FREE, supporter donation is optional.
The February meeting will feature three start-ups as well as keynote speaker Dr. Aubrey de Grey, Chief Science Officer at SENS Research Foundation, who will be speaking to "Rejuvenation Biotechnology: Why age may may cease to mean aging." Join them on Tuesday, February 21st at Plug and Play Tech Center in Sunnyvale, CA from 6 PM - 9 PM. | | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2017 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy | Terms of Use. | |
| _rgb_600_51.png) |
|
No comments:
Post a Comment